Project

VeRVe: Observational study of the use of venetoclax in patients with chronic lymphocytic leukemia (CLL) under real-life setting in Austria,Germany and Switzerland (Venetoclax Real Value)

Automatically Closed · 2020 until 2022

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Automatically Closed
Start Date
2020
End Date
2022
Financing
Industry
Keywords
Observational study, use of venetoclax, chronic lymphocyt-ic leukemia (CLL)
Brief description/objective